SPARK THERAPEUTICS, INC. Research and Development Expense
SPARK THERAPEUTICS, INC. reported Research and Development Expense of $32.83 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2018-11-06
- SPARK THERAPEUTICS, INC. research and development expense for the quarter ending 2018-09-30 was $32.83M, a 16.55% decline year-over-year.
- SPARK THERAPEUTICS, INC. research and development expense for the quarter ending 2018-06-30 was $25.52M, a 22.63% decline year-over-year.
- SPARK THERAPEUTICS, INC. research and development expense for the quarter ending 2018-03-31 was $30.11M, a 8.02% decline year-over-year.
- SPARK THERAPEUTICS, INC. research and development expense for the quarter ending 2017-09-30 was $39.34M, a 75.75% increase year-over-year.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed |
|---|---|---|---|---|---|---|
| 2018-09-30 | $32.83M 10-Q · filed 2018-11-06 | $58.35M derived: sum of 2 quarters · filed 2018-11-06 | $88.46M 10-Q · filed 2018-11-06 | |||
| 2018-06-30 | $25.52M 10-Q · filed 2018-08-08 | $55.63M 10-Q · filed 2018-08-08 | ||||
| 2018-03-31 | $30.11M 10-Q · filed 2018-05-08 | |||||
| 2017-09-30 | $39.34M 10-Q · filed 2018-11-06 | $39.34M 10-Q · filed 2017-11-07 | $72.33M derived: sum of 2 quarters · filed 2018-11-06 | $104.68M 10-Q · filed 2018-11-06 | $104.68M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $32.99M 10-Q · filed 2018-08-08 | $32.99M 10-Q · filed 2017-08-02 | $65.34M 10-Q · filed 2018-08-08 | $65.34M 10-Q · filed 2017-08-02 | ||
| 2017-03-31 | $32.73M 10-Q · filed 2018-05-08 | $32.74M 10-Q · filed 2017-05-10 | ||||
| 2016-09-30 | $22.38M 10-Q · filed 2017-11-07 | $42.01M derived: sum of 2 quarters · filed 2017-11-07 | $60.26M 10-Q · filed 2017-11-07 | |||
| 2016-06-30 | $19.62M 10-Q · filed 2017-08-02 | $37.87M 10-Q · filed 2017-08-02 | ||||
| 2016-03-31 | $18.25M 10-Q · filed 2017-05-10 | |||||
| 2015-09-30 | $11.80M 10-Q · filed 2016-11-04 | $21.14M derived: sum of 2 quarters · filed 2016-11-04 | $29.47M 10-Q · filed 2016-11-04 | |||
| 2015-06-30 | $9.34M 10-Q · filed 2016-08-10 | $17.68M 10-Q · filed 2016-08-10 | ||||
| 2015-03-31 | $8.33M 10-Q · filed 2016-05-06 | |||||
| 2014-09-30 | $4.65M 10-Q · filed 2015-11-06 | $6.78M derived: sum of 2 quarters · filed 2015-11-06 | $10.17M 10-Q · filed 2015-11-06 | |||
| 2014-06-30 | $2.13M 10-Q · filed 2015-08-07 | $5.52M 10-Q · filed 2015-08-07 | ||||
| 2014-03-31 | $3.39M 10-Q · filed 2015-05-11 |